Two Sigma Securities’s Bionano Genomics BNGO Stock Holding History
Bought
Maintained
Sold
Other funds holding BNGO
GCP
CAM
XT
Two Sigma Securities's BNGO Position: Q2 2026 in Review
Two Sigma Securities sold out of Bionano Genomics (BNGO) in Q2 2026, closing a stake of 18,056 shares — an estimated $21.1K sold.
Two Sigma Securities first reported a position in BNGO in Q4 2019 and held it in 12 quarters. The position peaked at $238K in Q3 2021. 34 funds tracked by Wall St. Rank hold BNGO as of Q2 2026.
- Two Sigma Securities reported no remaining Bionano Genomics position as of Q2 2026 after selling out during the quarter.
- Two Sigma Securities sold 18,056 Bionano Genomics shares in Q2 2026, an estimated $21.1K.
- Two Sigma Securities first reported a position in Bionano Genomics in Q4 2019 and held it in 12 quarters.
- Two Sigma Securities's Bionano Genomics position peaked at $238K in Q3 2021.
- 34 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2026.
Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.